✨ Free AI Report
RxSight, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research RxSight, Inc.
Company Research

RxSight, Inc.: Business Overview, Financials & Competitive Analysis

RxSight, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). High-growth medtech company targeting premium cataract segment with differentiated technology, but profitability timeline uncertain amid execution challenges and market headwinds. RxSight demonstrates strong revenue growth (57% in 2024, 57% of 2025 midpoint guidance) and expanding unit adoption, but faces near-term challenges including 2025 guidance cuts (down 25-31% from original), negative.

What is RxSight, Inc.'s industry? RxSight, Inc. (rxsight.com) operates in Ophthalmic Medical Devices / Premium Intraocular Lenses (IOL). AskCyborg classifies RxSight, Inc. under Ophthalmic Medical Devices / Premium Intraocular Lenses (IOL) in its company registry.

RxSight is an ophthalmic medical device company specializing in Light Adjustable Intraocular Lenses (LAL) for post-cataract surgery patients. The company's proprietary RxSight system enables surgeons to customize and ...

5/ 10Mixed

Cyborg Score thesis

High-growth medtech company targeting premium cataract segment with differentiated technology, but profitability timeline...

Read the full analyst-debate transcript →
Industry Ophthalmic Medical Devices / Premium Intraocular Lenses (IOL)
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest RxSight, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for RxSight, Inc.

AskCyborg analysts argue the bull and bear cases for RxSight, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
RxSight, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

RxSight, Inc. Overview

Pro stress-test →

RxSight is an ophthalmic medical device company specializing in Light Adjustable Intraocular Lenses (LAL) for post-cataract surgery patients. The company's proprietary RxSight system enables surgeons to customize and optimize patient vision outcomes after cataract surgery through adjustable photosensitive lenses and UV light delivery devices, addressing a significant market opportunity in the premium IOL segment.

Strategic Profile

Pro stress-test →

RxSight has rapidly scaled adoption to reach 15% of North American cataract surgeons with LAL procedures capturing over 10% of the regional premium IOL market. The company's strategy focuses on clinical validation, surgeon education, device installation expansion (1,084 units installed base), and international expansion to unlock higher market penetration and drive gross margins toward 73-74%.

Competitive Landscape

Pro stress-test →

RxSight operates in the premium intraocular lens (IOL) market dominated by large established medtech companies. Primary competitors include Alcon (LenSx laser-assisted cataract surgery), Bausch + Lomb, Johnson & Johnson Vision, and Carl Zeiss Meditec, all offering premium IOL alternatives. RxSight's unique value proposition is post-surgery customization rather than pre-surgery optimization, differentiating it but limiting addressable market to premium patients seeking fine-tuning.

Industry Context

RxSight, Inc. operates in Ophthalmic Medical Devices / Premium Intraocular Lenses (IOL).

Key facts

Founded: 1997 · Headquarters: Aliso Viejo, California · Revenue: $139.9M (2024) / $120-130M (2025E) · Market cap: $0.41B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on RxSight, Inc..

  • Strong LAL procedure volume growth (+13% YoY to 27,380 in Q2 2025) despite revenue pressure from LDD sales decline (-49% YoY), indicating product adoption outpacing monetization
  • Significant guidance reduction for 2025 (from $160-175M to $120-130M) signals execution challenges, though gross margin improvement to 72-74% shows path to profitability
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Stock trading near $10 after 52-week decline from $37, reflecting market repricing of profitability expectations
  • February 2026Piper Sandler raised price target to $11 from $10, maintaining analyst support despite recent headwinds
  • +2 moreTrack every material event for RxSight, Inc. as it happens. Explore monitoring →
Get alerted when RxSight, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Laser-Assisted Cataract Surgery SystemsPre-operative cataract surgery optimization technology→Premium IOL ProductsTraditional premium intraocular lenses and vision correction platforms→Premium Cataract Surgery SolutionsComprehensive cataract and vision correction products→

Compare RxSight, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

RxSight, Inc. operates in Ophthalmic Medical Devices / Premium Intraocular Lenses (IOL). See how the rest of the sector scores on the Cyborg framework.

Browse Ophthalmic Medical Devices / Premium Intraocular Lenses (IOL) research →
NEW · MCP server

Ask your AI assistant about RxSight, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare RxSight, Inc. and its top competitor on Cyborg Score”
“What did RxSight, Inc. do this quarter?”
“Is RxSight, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does RxSight, Inc. do?+
RxSight is an ophthalmic medical device company specializing in Light Adjustable Intraocular Lenses (LAL) for post-cataract surgery patients. The company's proprietary RxSight system enables surgeons to customize and ...
What is RxSight, Inc.'s Cyborg Score?+
RxSight, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are RxSight, Inc.'s main competitors?+
Named competitors include Laser-Assisted Cataract Surgery Systems, Premium IOL Products, Premium Cataract Surgery Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full RxSight, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the RxSight, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track RxSight, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.